Mehran Score for Post-PCI Contrast Nephropathy
Estimates the risk of contrast‑induced nephropathy after PCI based on clinical and procedural factors.
Indicazioni d'uso
Used in adults undergoing coronary angiography/PCI to identify patients at higher risk of post‑contrast AKI so preventive measures (hydration, contrast minimization, high‑dose statins) can be intensified. Applies to stable or ACS presentations; strongest predictors and validation come from PCI cohorts 1 [Level II evidence], with contemporary validation confirming risk discrimination 2 [Level II evidence]. Helps guide periprocedural strategy but not a substitute for clinical judgment.
Approfondimenti e precauzioni
Identifies high-risk patients reasonably well but tends to overestimate absolute risk in contemporary PCI cohorts (external validations show C‑statistics ~0.61–0.68) 1 [Level II evidence].
Use cautiously in STEMI, hemodynamic instability, and high-contrast PCI, where risk is often underestimated.
Should not guide prophylaxis alone; hydration and minimizing contrast volume remain key 2 [Level I evidence].